Tirzepatide May Lower Some Inflammatory Markers Research suggests tirzepatide may reduce blood markers associated with systemic inflammation, including high-sensitivity C-reactive protein and interleukin-6
These therapies are often customized based on individual needs, hormone panels, and nutrient deficiencies
These include: Paraesthesia (pins and needles) in hands and feet Peripheral neuropathy with numbness or altered sensation Difficulty walking or balance problems (ataxia) Memory problems and cognitive difficulties Mood changes, including depression or irritability In severe cases, confusion or dementia-like symptoms Other manifestations may include: Loss of appetite and unintentional weight loss Constipation Visual disturbances (rare, but can occur with optic neuropathy) Important: The neurological complications of B12 deficiency can progress even in the absence of anaemia, making early detection crucial
When Zepbound is taken with other prescription drugs, over-the-counter medications, vitamins, herbal products, and supplements, it may change how they work or increase the risk of side effects
In this direction, harnessing the ligand-receptor affinity, an aptamer AS1411 to nucleolin has been developed [189]
